CRM(SZ:000927)2022-04-27 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥13,100,448,195.25, representing a 17.06% increase compared to ¥11,191,188,165.37 in the same period last year[1] - Net profit attributable to shareholders was ¥211,084,477.99, up 5.34% from ¥200,379,041.07 year-on-year[1] - The net profit after deducting non-recurring gains and losses was ¥209,368,891.97, reflecting a 7.78% increase from ¥194,246,961.55 in the previous year[1] - Total operating revenue for Q1 2022 reached CNY 13.10 billion, an increase of 17.06% compared to CNY 11.19 billion in Q1 2021[9] - Total operating costs for Q1 2022 were CNY 12.78 billion, up 16.83% from CNY 10.94 billion in the same period last year[9] - Net profit attributable to shareholders of the parent company was CNY 211.08 million, a rise of 5.84% from CNY 200.38 million in Q1 2021[10] - The total comprehensive income for Q1 2022 was CNY 232.13 million, compared to CNY 210.91 million in the same period last year[10] - Basic and diluted earnings per share remained at CNY 0.03 for both Q1 2022 and Q1 2021[10] Cash Flow and Financing - The net cash flow from operating activities was -¥2,988,508,129.86, a decrease of 115.41% compared to -¥1,387,327,911.47 in the same period last year[1] - The company reported a net cash outflow from operating activities of CNY -2.99 billion, compared to CNY -1.39 billion in Q1 2021[11] - Cash inflow from financing activities totaled CNY 2.81 billion, significantly higher than CNY 1.35 billion in Q1 2021[11] Assets and Liabilities - Total assets at the end of the reporting period were ¥32,394,914,056.01, an increase of 9.05% from ¥29,707,796,535.00 at the end of the previous year[1] - The company's current assets totaled CNY 28,032,110,702.78, up from CNY 25,254,779,636.81, indicating an increase of about 11.0%[7] - Total liabilities amounted to CNY 23,409,222,486.22, up from CNY 20,951,254,450.95, indicating an increase of about 11.0%[8] - The company's equity attributable to shareholders reached CNY 7,931,725,340.74, compared to CNY 7,720,779,302.73, showing an increase of approximately 2.7%[8] Receivables and Inventory - The company's receivables increased by 205.53% to ¥675,630,101.76 due to an increase in commercial acceptance bill settlements[4] - Inventory rose by 30.61% to ¥2,868,396,762.17, attributed to business expansion and increased procurement scale[4] - Accounts receivable rose to CNY 11,740,317,650.62 from CNY 10,736,729,196.44, marking an increase of about 9.3%[7] - Inventory increased to CNY 2,868,396,762.17 from CNY 2,196,215,522.05, representing a growth of about 30.5%[7] - The company reported a rise in other receivables to CNY 1,487,982,899.35 from CNY 297,073,829.97, indicating a significant increase of approximately 400.0%[7] Borrowings and Financial Health - Short-term borrowings increased by 28.41% to ¥3,391,615,909.80 due to increased external financing[4] - Short-term borrowings increased to CNY 3,391,615,909.80 from CNY 2,641,267,261.78, reflecting a growth of approximately 28.5%[8] - The weighted average return on net assets decreased by 0.26 percentage points to 2.70%[1] - The total non-current assets decreased to CNY 4,362,803,353.23 from CNY 4,453,016,898.19, reflecting a decline of about 2.0%[7] Research and Development - Research and development expenses decreased to CNY 2.77 million from CNY 3.01 million year-on-year[9] - The company’s financial assets impairment loss was CNY -15.05 million, compared to a gain of CNY 6.84 million in Q1 2021[9] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 52,870[5]